Navigation Links
Whites take supplemental breast cancer therapy more often than blacks

ANN ARBOR, Mich.---A new study finds that white women more frequently take more of the life-prolonging supplemental therapies used to treat breast cancer than African-American women.

African-Americans whose cancer had spread to the lymph nodes were less likely to have adjuvant cancer therapy than white women, the study showed. Adjuvant therapy is treatment given to kill remaining cancer cells, in addition to the primary therapy. Studies suggest adjuvant therapy may increase the chances of long-term survival.

The study, which was led by Dr. Mousumi Banerjee of the University of Michigan School of Public Health, found that among women whose cancer had spread or become regional in nature, whites were almost five times more likely to take tamoxifen, a widely-used adjuvant cancer therapy medication, and more than three times more likely to have adjuvant chemotherapy. White and African American women with cancer that had not spread received tamoxifen and chemotherapy at equal rates.

There was no significant difference in the numbers of white and African American women who received breast conservation surgery versus mastectomy. However, women with early stage breast cancer who were covered by government health insurance were less likely to have combination breast conserving cancer surgery and radiation, and more likely to have mastectomy without radiation than patients enrolled in non-governmental plans, or private plans.

"We have seen that African American women are not getting the optimal therapy as often as white Americans," said Banerjee, but she added it's a combination of different things. "Some of it has to do with socioeconomics, some with insurance status and/or access to care, but there are choice issues as well, especially with chemotherapy."

In the study, researchers reviewed and analyzed demographic, socioeconomic and medical data from 651 women diagnosed with breast cancer in Detroit in the early to mid 1990s. Their objective was to evaluate the role of race in breast cancer treatment after accounting for such significant variables as socioeconomic status, health insurance status, and other medical conditions that exist along with the breast cancer that may preclude use of certain treatments.

Racial differences in the diagnosis and outcome of breast cancer have been readily apparent since the 1980s, when new screening and treatment tools became available. Breast cancer is diagnosed at a more advanced, poor prognostic stage among African-American women than white American women. Studies also suggest that, stage-for-stage, African-American women have higher cancer mortality rates. Differences in access to screening and treatment infrastructure, rather than tumor biology, may account for differences in clinical course.

One conclusion from this study is to target educational interventions in a culturally sensitive way to improve use of adjuvant therapies among African-American women with advanced stage disease.


Contact: Laura Bailey
University of Michigan

Related medicine news :

1. Asian-American Teens More Likely Than Whites to Learn Healthier Lifestyles
2. Black Women Have More Severe Cases of Breast Cancer Than Whites, Hispanics
3. Blacks Get Treatment on Par With Whites for Cardiovascular Disease
4. Minority Women in LA County Have Higher Rates of Chronic Disease Than Whites
5. Whites Have Highest Risk of Diabetes in U.S
6. New Supplemental Therapy for Common Jaw Disorder
7. Bayer and Onyx Submit Supplemental New Drug Application for Nexavar to Treat Liver Cancer
8. Consensus on "Combination Therapy" for Breast Cancer
9. Breast cancer treatment to be determined by gene test
10. Ductal lavage may detect early breast cancer
11. Breast Feeding prevents obesity later on in life
Post Your Comments:
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... a startling report released today, National Safety Council research ... proven plan to eliminate prescription opioid overdoses. Prescription Nation ... tackling the worst drug crisis in recorded U.S. history, assigned a ... , New Mexico , Tennessee ... failing states, three – Michigan , ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
(Date:6/23/2016)... 2016  Guerbet announced today that it has been ... Award . One of 12 suppliers to ... its support of Premier members through exceptional local customer ... commitment to lower costs. ... our outstanding customer service from Premier," says Massimo ...
Breaking Medicine Technology: